** Shares of LBT Innovations rise as much as 73.3% to A$0.026, their highest since April 5
** Stock posts its biggest intraday pct gain since March 13
** Medical technology firm says it has signed agreement to sell five APAS Independence instruments to AstraZeneca with total contract value between $2.2 mln and $2.7 mln
** APAS Independence is an in vitro diagnostic instrument for the automated imaging, analysis and interpretation of agar culture plates
** About 9.9 mln LBT shares change hands, compared with the 30-day average volume of 1.5 mln
** Stock had risen 36.4% this year, as of last close
(Reporting by Sneha Kumar in Bengaluru)
((Sneha.Kumar@thomsonreuters.com;))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。